A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Among the earliest invariant neuropathological changes in Alzheimer's disease (AD) is the degeneration of vulnerable hippocampal CA1 and subicular pyramidal neurons. Semaphorin 3A (Sema3A) is a secreted protein that functions in signaling growth cone collapse, chemorepulsion and neuronal apoptosis during early development of the central nervous system. In this report we show that accumulation of an internalized form of Sema3A is associated with degeneration of neurons in vulnerable fields of the hippocampus during AD. Accumulation of Sema3A overlaps the appearance of phosphorylated MAP1B and tau in many neurons, suggesting that Sema3A signaling at some level may be coupled to these previously identified cytoskeletal markers of neurodegeneration. Consistent with this, we isolated and partially characterized a multiprotein complex from the hippocampus of patients with AD that contains phosphorylated MAP1B, collapsin‐response mediator protein 2 (CRMP‐2), Plexins A1 and A2, and a processed form of Sema3A. A model is presented in which aberrant release of Sema3A from expressing neurons in the subiculum during AD results in the internalization and transport of Sema3A from this field to CA1. Within the context of the myriad of potential insults that contribute to Alzheimer's and other neurodegenerative diseases, the bioactivity of Sema3A may contribute either directly to neurodegeneration by inducing neuronal collapse, or indirectly by abrogating the recovery capabilities of adult neurons faced with these insults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“The MS/MS spectra (fragmentation spectra) were correlated with known sequences using an algorithm [Sequest; (Eng et al. 1994)] and programs developed in the Harvard Microchemistry Facility (Chittum et al. 1998).”
MethodGage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786 · cited 1×
“Ongoing neurogenesis continues in the dentate gyrus and olfactory system of adult mammals, including humans (Gage 2000).”
BackgroundWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
Price, J. L., Davis, P. B., Morris, J. C., & White, D. L. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90006-6 · Cited by 818 · cited 1×
“Neurodegeneration of selectively vulnerable subfields of the hippocampal formation (Braak and Braak 1991; Price et al. 1991) is central to the earliest pathogenesis of Alzheimer’s disease (AD).”
BackgroundMitotic mechanisms in Alzheimer's disease?
Vincent, I., Rosado, M., & Davies, P. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.3.413 · Cited by 386
Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules.
Trinczek, B., Biernat, J., Baumann, K., Mandelkow, E. M., & Mandelkow, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.12.1887 · Cited by 340 · cited 1×
“Phosphorylation of tau by these enzymes generates phosphoforms comparable with those present in the paired helical filaments that accrue during the progression of AD (Baumann et al. 1993; Lovestone et al. 1994; Trinczek et al. 1995; Flaherty et al. 2000; Sato et al. 2002; Noble et al. 2003).”
BackgroundBOBINSKI, M., WEGIEL, J., TARNAWSKI, M., BOBINSKI, M., REISBERG, B., DE LEON, M. J., MILLER, D. C., & WISNIEWSKI, H. M. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00010 · Cited by 208 · cited 1×
“Additionally, we have demonstrated that CA3 neurons lack phosphorylated MAP1B in all but the advanced AD cases where CA3 neurons are lost as well (Bobinski et al. 1997).”
BackgroundBennecib, M., Gong, C.-X., Grundke-Iqbal, I., & Iqbal, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02203-1 · Cited by 184 · cited 1×
“Sustained activation of CDK5 and GSK-3, or inhibition of reciprocal phosphatase activities (Bennecib et al. 2000; Planel et al. 2001), may result in pathogenic hyperphosphorylation of microtubule-associated proteins tau and MAP1B during AD.”
BackgroundXu, R., Janson, C., Mastakov, M., Lawlor, P., Young, D., Mouravlev, A., Fitzsimons, H., Choi, K.-L., Ma, H., Dragunow, M., et al. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301529 · Cited by 174 · cited 2×
“Other studies have shown that injected AAV expression vehicles transduce the CNS with adequate efficiency (Xu et al. 2001), and that they display a selective neurotrophism in the mammalian brain (Kaplitt et al.”
Background
Cited by
CNS immune privilege: hiding in plain sight
Carson, M. J., Doose, J. M., Melchior, B., Schmid, C. D., & Ploix, C. C. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00441.x · Cited by 795
Semaphorins and their Signaling Mechanisms
Alto, L. T., & Terman, J. R. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6448-2_1 · Cited by 429
Uchida, Y., Ohshima, T., Sasaki, Y., Suzuki, H., Yanai, S., Yamashita, N., Nakamura, F., Takei, K., Ihara, Y., Mikoshiba, K., et al. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00827.x · Cited by 410
Induction of Autophagy in Axonal Dystrophy and Degeneration
Wang, Q. J., Ding, Y., Kohtz, S., Mizushima, N., Cristea, I. M., Rout, M. P., Chait, B. T., Zhong, Y., Heintz, N., & Yue, Z. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2261-06.2006 · Cited by 308
“Antibodies used in this study include mouse monoclonal calbindin D-28K antibody (1:1000; Swant, Bellinzona, Switzerland), mouse monoclonal neuronal-specific nuclear protein (NeuN) antibody (1:200; Chemicon, Temecula, CA), mouse monoclonal phospho-Tau antibody AT-8 (1:250; Innogenetics, Gent, Belgium), mouse monoclonal…”
InfluentialAxon guidance proteins in neurological disorders
Van Battum, E. Y., Brignani, S., & Pasterkamp, R. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70257-1 · Cited by 241
Metadata
- Authors
- Good, P. F., Alapat, D., Hsu, A., Chu, C., Perl, D., Wen, X., Burstein, D. E., & Kohtz, D. S.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2004-09-27
- Volume
- 91
- Issue
- 3
- Pages
- 716-736
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2006291295
- Cited by
- 147
- References
- 10
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.